Newborn screening testing services for brian d. Allgood army community hospital (bddach), korea. Base period (29 september 2024 - 28 september 2025) plus four (4) one-year option periods.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- W81K0224D0009
- Awardee
-
Revvity Omics Inc. UEI LDJULX8K6M85 Part of Revvity Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 3 $88,488 obligated
Award facts
- Opportunity
-
- Newborn Screening Testing Services for Brian D. Allgood Army Community Hospital (BDAACH), USAMEDDAC-Korea Pre-Solicitation · W81K0224Q0099 · Posted Jul 11, 2024
- Combined order value
- $88,488 Current and potential, with all options
- Last date to order 42% complete
- IDV ceiling 29% used
- $301,668.00
- Maximum order
- $301,668.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded a single-award Indefinite Delivery Contract to Revvity Omics Inc. on September 29, 2024, with a ceiling of $301,668 and an ultimate completion date of September 28, 2029.
The contract covers newborn screening testing services for Brian D. Allgood Army Community Hospital in South Korea. Performance encompasses a base period from September 29, 2024, through September 28, 2025, plus four one-year option periods extending through September 28, 2029. Place of performance is South Korea.
The originating solicitation sought a single-award IDIQ for newborn screening testing services under NAICS 621511 (Medical and Diagnostic Laboratories). The Department of the Army Medical Command required the contractor to provide all personnel, equipment, material, and supervision necessary to perform testing services as defined in the performance work statement. No set-aside was applied; all sources were eligible, though the Republic of Korea–United States Status of Forces Agreement required offerors to demonstrate authorization and capacity to conduct business in South Korea.
Three delivery orders have been issued under this IDIQ. The Defense Health Agency awarded a $40,945.50 delivery order on September 29, 2024, covering the base period through September 28, 2025. A second delivery order for $4,549.50 was awarded July 1, 2025, with completion by September 28, 2025. A third delivery order valued at $42,993 was awarded September 29, 2025, with completion by September 28, 2026. All orders are firm fixed-price with no set-aside applied.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract W81K0224D0009?
W81K0224D0009 was awarded to Revvity Omics Inc. by Defense Health Agency (Department of Defense) on September 29, 2024.
How much is contract W81K0224D0009 worth?
Orders under W81K0224D0009 have obligated $88,488. W81K0224D0009's own ceiling is $301,668. A single order can be worth up to $301,668.
How many orders have been placed under contract W81K0224D0009?
3 orders have been placed under W81K0224D0009, the latest on September 29, 2025.
Who can order from contract W81K0224D0009?
W81K0224D0009 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract W81K0224D0009 competed?
The extent of competition for W81K0224D0009 was competed under sap. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV